Prevention and treatment of atrial fibrillation in patients with cardiovascular disease can significantly reduce mortality, stroke incidence, and medical costs.
Does prevention and treatment of AF reduce mortality, stroke, and medical costs in patients with AF and associated CVD?
Patients with atrial fibrillation (AF) and associated cardiovascular disease (CVD)
Prevention of AF and treatment
Mortality, stroke, and medical costshard clinical
Prevention and treatment of atrial fibrillation and associated cardiovascular disease may reduce mortality, stroke, and health care costs.
Absolute Event Rate: 0% vs 0%
Prevention of AF and treatment of patients with AF and associated CVD may yield benefits in reduced mortality and stroke as well as reducing health care costs.
Building similarity graph...
Analyzing shared references across papers
Loading...
Philip A. Wolf
General Cardiology
Janet B. Mitchell
Boston University
Colin S. Baker
Merck & Co., Inc., Rahway, NJ, USA (United States)
Archives of Internal Medicine
Boston University
Building similarity graph...
Analyzing shared references across papers
Loading...
Wolf et al. (Mon,) reported a other. Prevention and treatment of atrial fibrillation in patients with cardiovascular disease can significantly reduce mortality, stroke incidence, and medical costs.
synapsesocial.com/papers/698574acba3aac942625327d — DOI: https://doi.org/10.1001/archinte.158.3.229